Women's Health News

RSS

Emphasizing STD prevention will persuade young women to get HPV vaccine, study suggests

The HPV vaccine can prevent both cervical cancer and a nasty sexually transmitted disease in women.

3 May 2013

Variations in the sequencing of TERT gene influence risk of breast, ovarian cancers

A major international study involving a Simon Fraser University scientist has found that sequence differences in a gene crucial to the maintenance of our chromosomes' integrity predispose us to certain cancers.

3 May 2013

Measurement variation influences gene expression profiles of breast cancer

An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.

3 May 2013

New findings to benefit women with oestrogen-receptor positive breast cancer

A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit from prolonged endocrine treatment.

3 May 2013

Researchers find association between DCIS Score and risk of developing IBE

The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.

3 May 2013

Research findings suggest new treatment for breast, colon, melanoma and other cancers

A common cancer pathway causing tumor growth is now being targeted by a number of new cancer drugs and shows promising results.

3 May 2013

Better individual risk prediction for women with breast cancer is getting nearer, says study author

A test that measures the expression levels of 58 genes in oestrogen receptor-positive breast cancers can effectively differentiate between patients who are at higher and lower risk for having their cancer recur elsewhere in the body more than five years after diagnosis, researchers report.

3 May 2013

Study may help diagnose endometrial cancer and lead to new drug development

Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan-Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) Research Network.

2 May 2013

Study: 98% of women are satisfied with breast augmentation results

Ninety-eight percent of women undergoing breast augmentation surgery say the results met or exceeded their expectations, according to a prospective outcome study published in the May issue of Plastic and Reconstructive Surgery-, the official medical journal of the American Society of Plastic Surgeons (ASPS).

2 May 2013

Adrenomedullin plays a crucial role in preventing preeclampsia

In a study using mice, researchers from the University of North Carolina at Chapel Hill found that a hormone, adrenomedullin, plays a crucial role in preventing the pregnancy complication preeclampsia.

2 May 2013

Study brings opportunities of personalised therapy for breast cancer a step closer

A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.

2 May 2013

Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced results from two studies that are featured in oral presentations this week at IMPAKT Breast Cancer Conference.

2 May 2013

EventusDx receives CE mark designation for Octava Pink breast cancer test

Eventus Diagnostics, Inc. today announced that it has received CE mark designation for its Octava Pink™ breast cancer test intended for confirmatory use in women who have received negative mammography results.

2 May 2013

First Edition: May 2, 2013

Today's headlines include reports about a new study detailing how expanded Medicaid access impacts beneficiaries' utilization of health care services and their overall physical health.

2 May 2013

To reach 'FP2020' goal, targets must be re-examined

Participants at the 2012 London Family Planning Summit "pledged $2.6 billion dollars in additional funding to achieve a worthy goal: provide 120 million new women who have 'unmet need' with family planning products and services by 2020 in 69 of the world's poorest countries," a movement dubbed "FP2020," Christopher Purdy, executive vice president of DKT International, writes in the Huffington Post's "Global Motherhood" blog.

2 May 2013

Women's Health News

Emphasizing STD prevention will persuade young women to get HPV vaccine, study suggests

Variations in the sequencing of TERT gene influence risk of breast, ovarian cancers

Measurement variation influences gene expression profiles of breast cancer

New findings to benefit women with oestrogen-receptor positive breast cancer

Researchers find association between DCIS Score and risk of developing IBE

Research findings suggest new treatment for breast, colon, melanoma and other cancers

Better individual risk prediction for women with breast cancer is getting nearer, says study author

Study may help diagnose endometrial cancer and lead to new drug development

Study: 98% of women are satisfied with breast augmentation results

Adrenomedullin plays a crucial role in preventing preeclampsia

Study brings opportunities of personalised therapy for breast cancer a step closer

Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with early-stage breast cancer

EventusDx receives CE mark designation for Octava Pink breast cancer test

First Edition: May 2, 2013

To reach 'FP2020' goal, targets must be re-examined

Study shows efficacy of PEGylated liposomal doxorubicin in intracranial model of breast cancer

Women's health care proves challenging for VA system

Viewpoints: Outrage at mistaken report on Hill health coverage; Two views of Florida's option on Medicaid

Genomics-based testing could change recommended course of treatment for endometrial cancer

Some American ob/gyn residency programs fail to offer formal training in menopause medicine

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News